Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

46.29 -0.97 (-2.05%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,094,588
Open 47.21
Bid (Size) 46.35 (1)
Ask (Size) 46.80 (1)
Prev. Close 47.26
Today's Range 45.51 - 47.21
52wk Range 43.42 - 91.10
Shares Outstanding 78,935,098
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Deciphering Disruption: Inside Cathie Wood's Latest Plays
Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies. 
Via MarketBeat
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
Via The Motley Fool

Performance

YTD
-29.93%
-29.93%
1 Month
-3.64%
-3.64%
3 Month
-2.55%
-2.55%
6 Month
-16.94%
-16.94%
1 Year
-34.33%
-34.33%

More News

Read More
Where Will CRISPR Therapeutics Be in 3 Years?
Via The Motley Fool
3 Unstoppable Growth Stocks I'm Loading $25,000 Each Into by 2029
Via The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Smaller Cap Biotechs Are In Season: How Are We Doing?
Via Talk Markets
3 Companies Building Tomorrow's Game-Changing Technologies
Via The Motley Fool
Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers
Via The Motley Fool
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Via Benzinga
Topics ETFs Stocks
Exposures US Equities
12 High-Growth Stocks That Could Deliver Parabolic Returns
Via The Motley Fool
The Ultimate Biotech Stock to Buy With $50 Right Now
Via The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Why We Buy Stocks
Via The Motley Fool
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Via The Motley Fool
Why I Keep Buying These 14 Incredible Growth Stocks
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Is CRISPR Therapeutics Stock a Buy?
Via The Motley Fool
2 Biotech Stocks That Are Screaming Buys This Month
Via The Motley Fool
This Healthcare Growth Stock Could Be a Steal of a Deal Right Now
Via The Motley Fool
These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer
Via The Motley Fool
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
Via Investor's Business Daily
3 Dirt Cheap Stocks to Buy Right Now
Via The Motley Fool
Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?
Via The Motley Fool
1 Biotech Stock Down 62% to Buy and Hold
Via The Motley Fool
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
Via The Motley Fool
Looking for Stock Bargains With Room to Run? Try This.
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS